DOTmed September 29, 2022
John R. Fischer

UK Biobank has partnered with the Medical Research Council, Calico Life Sciences and the Chan Zuckerberg Initiative on a $30 million endeavor to utilize repeat scanning on 60,000 participants to better track and understand disease progression in humans as they age.

The first phase of the baseline project began in 2014 and has resulted in the world’s largest imaging data set. Researchers involved have captured MR data from the brains, hearts and abdomens; bone density; and ultrasound scans of the carotid arteries for over 50,000 participants.

They plan to collect more from up to 100,000 over the next two years and will initiate a second phase, which involves repeat imaging on 60,000, two to seven years after their initial scan....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Provider, Radiology
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs
Big Pharma's ROI for drug R&D saw 'welcome' rebound in 2023: report
STAT+: Why a British hospital, and not a drugmaker, is trying to get a rare disease therapy approved
STAT+: Profiting from ‘legal’ insider trading isn’t always easy
Regeneron expands in gene editing with Mammoth deal

Share This Article